ATE303448T1 - Duale selektionkassette und sie enthaltende plasmide - Google Patents

Duale selektionkassette und sie enthaltende plasmide

Info

Publication number
ATE303448T1
ATE303448T1 AT98950669T AT98950669T ATE303448T1 AT E303448 T1 ATE303448 T1 AT E303448T1 AT 98950669 T AT98950669 T AT 98950669T AT 98950669 T AT98950669 T AT 98950669T AT E303448 T1 ATE303448 T1 AT E303448T1
Authority
AT
Austria
Prior art keywords
selection cassette
replication
plasmid
provides
dual selection
Prior art date
Application number
AT98950669T
Other languages
English (en)
Inventor
Duncan L Mcvey
Douglas E Brough
Imre Kovesdi
Original Assignee
Genvec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genvec Inc filed Critical Genvec Inc
Application granted granted Critical
Publication of ATE303448T1 publication Critical patent/ATE303448T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98950669T 1997-09-23 1998-09-23 Duale selektionkassette und sie enthaltende plasmide ATE303448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5982497P 1997-09-23 1997-09-23
PCT/US1998/020009 WO1999015686A1 (en) 1997-09-23 1998-09-23 Plasmids for construction of eukaryotic viral vectors

Publications (1)

Publication Number Publication Date
ATE303448T1 true ATE303448T1 (de) 2005-09-15

Family

ID=22025510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98950669T ATE303448T1 (de) 1997-09-23 1998-09-23 Duale selektionkassette und sie enthaltende plasmide

Country Status (8)

Country Link
US (2) US6329200B1 (de)
EP (1) EP1015620B1 (de)
JP (1) JP2001517455A (de)
AT (1) ATE303448T1 (de)
AU (1) AU749856B2 (de)
CA (1) CA2304173A1 (de)
DE (1) DE69831417T2 (de)
WO (1) WO1999015686A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1111061A1 (de) * 1999-12-20 2001-06-27 Universite Libre De Bruxelles Vektor mit doppelter Selektion
WO2001059071A2 (en) * 2000-02-09 2001-08-16 Genvec, Inc. Methods of preparing and using a viral vector library
JP2003522160A (ja) * 2000-02-11 2003-07-22 ジェンベク、インコーポレイティッド 眼関連疾患の治療のための遺伝子治療
US6573092B1 (en) * 2000-10-10 2003-06-03 Genvec, Inc. Method of preparing a eukaryotic viral vector
FR2820146B1 (fr) * 2001-01-29 2003-06-27 Centre Nat Rech Scient Procede d'obtention de cellules d'encapsidation fortement productrices de retrovirus par elimination, au sein de la culture, des cellules permissives a l'infection par le retro virus produit
US20040166091A1 (en) 2003-02-24 2004-08-26 Genvec, Inc. Materials and methods for treating disorders of the ear
WO2005012537A2 (en) * 2003-07-25 2005-02-10 Genvec, Inc. Adenoviral vector-based vaccines
DE602004025726D1 (de) * 2003-11-14 2010-04-08 Genvec Inc Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
AU2005243730B2 (en) 2004-04-12 2010-05-27 Genvec, Inc. Method of using adenoviral vectors to induce an immune response
EP1784493A2 (de) * 2004-09-01 2007-05-16 The Government of the United States of America as Represented by The Department of Health and Human Services Adenovirale vektoren mit der fähigkeit zum umwandeln von apcs, mögliche verwendung bei immunantworterzeugung
JP5225069B2 (ja) 2005-03-23 2013-07-03 ゲンマブ エー／エス 多発性骨髄腫の治療のためのｃｄ３８に対する抗体
KR100658534B1 (ko) 2005-04-28 2006-12-19 재단법인서울대학교산학협력재단 제한효소 절단에 의한 클로닝에 기반을 둔 표적 유전자파쇄방법
WO2006135974A1 (en) * 2005-06-24 2006-12-28 Australian Centre For Plant Functional Genomics Pty Ltd Targeting vector
US9651543B2 (en) 2005-08-31 2017-05-16 The United States Of America As Represented By The Secretary Of The Navy Malaria antigen screening method
BRPI0615400A2 (pt) 2005-08-31 2011-05-17 Genvec Inc vacinas para malária baseadas em vetor adenoviral
US8450055B2 (en) * 2005-08-31 2013-05-28 The United States Of America As Represented By The Secretary Of The Navy Malaria antigen screening method
BRPI0618441B8 (pt) 2005-11-10 2021-07-27 Genvec Inc vetor adenoviral
US20080248060A1 (en) * 2007-01-09 2008-10-09 Genvec, Inc. Adenoviral vector-based malaria vaccines
EP2612867A1 (de) 2007-11-01 2013-07-10 Perseid Therapeutics LLC Immunsuppressive Polypeptide und Nucleinsäuren
KR20130010121A (ko) 2010-03-23 2013-01-25 인트렉손 코포레이션 치료적 단백질을 조건부로 발현하는 벡터，상기 벡터를 포함하는 숙주 세포 및 이의 용도
JP2011078436A (ja) * 2011-01-27 2011-04-21 National Institute Of Infectious Diseases プロテアーゼ活性の測定方法
JP6189754B2 (ja) 2011-03-04 2017-08-30 イントレキソン コーポレーション タンパク質を条件的に発現するベクター
JP7242180B2 (ja) 2014-09-07 2023-03-20 セレクタ バイオサイエンシーズ インコーポレーテッド 抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體
EP4219709A1 (de) * 2016-11-03 2023-08-02 Temple University - Of The Commonwealth System of Higher Education Dna plasmide für die schnelle herstellung von homologen rekombinationsvektoren für zelllinienentwicklung
MX2019008143A (es) 2017-01-07 2020-01-13 Selecta Biosciences Inc Dosificación sistemática de inmunosupresores acoplados a nanoportadores sintéticos.
BR112020007157A2 (pt) 2017-10-13 2020-09-24 Selecta Biosciences, Inc. métodos e composições para a atenuação de respostas de igm antivetor de transferência viral
GB2584211B (en) 2017-11-16 2023-05-24 Synthex Inc Selective modulation of protein-protein interactions
EP3962537A1 (de) 2019-04-28 2022-03-09 Selecta Biosciences, Inc. Verfahren zur behandlung von subjekten mit vorbestehender immunität gegen virusübertragungsvektoren
CN114206396A (zh) 2019-05-28 2022-03-18 西莱克塔生物科技公司 用于减弱抗病毒转移载体免疫应答的方法和组合物
CN118767143A (zh) 2019-12-12 2024-10-15 听治疗有限责任公司 用于预防和治疗听力损失的组合物和方法
US20230141563A1 (en) 2021-10-12 2023-05-11 Selecta Biosciences, Inc. Methods and compositions for attenuating anti-viral transfer vector igm responses
WO2023172624A1 (en) 2022-03-09 2023-09-14 Selecta Biosciences, Inc. Immunosuppressants in combination with anti-igm agents and related dosing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769331A (en) 1981-09-16 1988-09-06 University Patents, Inc. Recombinant methods and materials
US5876962A (en) 1987-08-12 1999-03-02 Natural Environment Research Council Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors
IL87394A0 (en) 1987-08-12 1989-12-15 Natural Environment Res Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing said vectors
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
FR2727689A1 (fr) 1994-12-01 1996-06-07 Transgene Sa Nouveau procede de preparation d'un vecteur viral
FR2730504B1 (fr) * 1995-02-13 1997-03-28 Rhone Poulenc Rorer Sa Procede de preparation de genomes d'adenovirus recombinants
WO1997025446A1 (en) 1996-01-05 1997-07-17 Genetic Therapy, Inc. Recombinase-mediated generation of adenoviral vectors
EP0996735B1 (de) * 1997-06-09 2003-12-10 Genvec, Inc. Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten
WO2001059071A2 (en) * 2000-02-09 2001-08-16 Genvec, Inc. Methods of preparing and using a viral vector library

Also Published As

Publication number Publication date
CA2304173A1 (en) 1999-04-01
US20020004242A1 (en) 2002-01-10
EP1015620B1 (de) 2005-08-31
JP2001517455A (ja) 2001-10-09
US6475757B2 (en) 2002-11-05
DE69831417T2 (de) 2006-06-22
AU749856B2 (en) 2002-07-04
AU9665598A (en) 1999-04-12
EP1015620A1 (de) 2000-07-05
US6329200B1 (en) 2001-12-11
DE69831417D1 (de) 2005-10-06
WO1999015686A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
ATE303448T1 (de) Duale selektionkassette und sie enthaltende plasmide
Lee et al. Construction of single-copy integration vectors for Staphylococcus aureus
Casadaban et al. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli
Barry A broad-host-range shuttle system for gene insertion into the chromosomes of Gram-negative bacteria
Pon et al. Identification, cloning, nucleotide sequence and chromosomal map location of hns, the structural gene for Escherichia coli DNA-binding protein H-NS
IN189732B (de)
WO1998056937A3 (en) Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
AU2812484A (en) Dna vectors and there use in recombinant dna technology
BR9712942A (pt) Método para a produção de glicerol, célula hospedeira transformada, método para a seleção da expressão do gene, cepa pah21/dh5x de escherichia coli e cepa pah21/dh5x de escherichia coli.
Uozumi et al. New cryptic plasmid of Bacillus subtilis and restriction analysis of other plasmids found by general screening
CA2179656A1 (en) Chromosomal expression of heterologous genes in bacterial cells
Kawamura et al. Isolation and mapping of a new suppressor mutation of an early sporulation gene spo0F mutation in Bacillus subtilis
Völker et al. One of two OsmC homologs in Bacillus subtilis is part of the ςB-dependent general stress regulon
PT83714A (en) Regulatory region cloning and analysis plasmid for bacillos
Teruo et al. Cloning vehicles for the homologous Bacillus subtilis host-vector system
Scott et al. Sequences of versatile broad-host-range vectors of the RK2 family
CN117487778A (zh) 一种全新的基于CRISPR-Cas12b的碱基编辑器的构建及其应用
Yoneda et al. Cloning of a foreign gene coding for α-amylase in Bacillussubtilis
AU591477B2 (en) Molecular cloning of the -endotoxin gene of bacillus thuringiensis var. israelensis
EP1144666A3 (de) Replikation -defektive baculoviren expressionssystem
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.
EP0120629A3 (de) Molekulare Klonierung mit bifunktionellen Plasmid-Vektoren in Bacillus subtilis, Mutante und wesentlich stabil transformierte Mutante von Bacillus subtilis und Verfahren zur Verwendung der transformierten Mutante
Meile et al. Potential shuttle vectors based on the methanogen plasmid pME2001
Caramori et al. The UP element of the promoter for the flagellin gene, hag, stimulates transcription from both SigD-and SigA-dependent promoters in Bacillus subtilis
DE3684017D1 (de) Vielfach amplifizierbare vektoren fuer hohe expression exogener dns.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties